{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T04:08:36Z","timestamp":1780632516908,"version":"3.54.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100005440","name":"Center for Scientific Review","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005440","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16058-3","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T09:18:52Z","timestamp":1776763132000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development of a multiplex assay for early detection of pancreatic cancer in high-risk groups"],"prefix":"10.1186","volume":"26","author":[{"given":"Sheng","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Karki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa A","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad J","family":"Creighton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa A","family":"Brentnall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall E","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"1","key":"16058_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"16058_CR2","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1001\/jama.2019.10232","volume":"322","author":"USPST Force","year":"2019","unstructured":"Force USPST, Owens DK, Davidson KW, Krist AH, Barry MJ, Cabana M, Caughey AB, Curry SJ, Doubeni CA, Epling JW Jr, et al. Screening for Pancreatic Cancer: US Preventive Services Task Force Reaffirmation Recommendation Statement. JAMA. 2019;322(5):438\u201344.","journal-title":"JAMA"},{"issue":"17","key":"16058_CR3","doi-asserted-by":"publisher","first-page":"2010","DOI":"10.1200\/JCO.2015.64.0730","volume":"34","author":"H Vasen","year":"2016","unstructured":"Vasen H, Ibrahim I, Ponce CG, Slater EP, Matthai E, Carrato A, Earl J, Robbers K, van Mil AM, Potjer T, et al. Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers. J Clin Oncol. 2016;34(17):2010\u20139.","journal-title":"J Clin Oncol"},{"issue":"4","key":"16058_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1053\/j.seminoncol.2007.05.003","volume":"34","author":"M Goggins","year":"2007","unstructured":"Goggins M. Identifying molecular markers for the early detection of pancreatic neoplasia. Semin Oncol. 2007;34(4):303\u201310.","journal-title":"Semin Oncol"},{"issue":"3","key":"16058_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/s00432-010-0965-x","volume":"137","author":"S Bunger","year":"2011","unstructured":"Bunger S, Laubert T, Roblick UJ, Habermann JK. Serum biomarkers for improved diagnostic of pancreatic cancer: a current overview. J Cancer Res Clin Oncol. 2011;137(3):375\u201389.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"15","key":"16058_CR6","doi-asserted-by":"publisher","first-page":"2705","DOI":"10.1002\/pmic.201400476","volume":"15","author":"S Pan","year":"2015","unstructured":"Pan S, Brentnall TA, Chen R. Proteomics analysis of bodily fluids in pancreatic cancer. Proteomics. 2015;15(15):2705\u201315.","journal-title":"Proteomics"},{"issue":"5","key":"16058_CR7","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1021\/pr101148r","volume":"10","author":"S Pan","year":"2011","unstructured":"Pan S, Chen R, Crispin DA, May D, Stevens T, McIntosh MW, Bronner MP, Ziogas A, Anton-Culver H, Brentnall TA. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. J Proteome Res. 2011;10(5):2359\u201376.","journal-title":"J Proteome Res"},{"key":"16058_CR8","doi-asserted-by":"crossref","unstructured":"Peng H, Pan S, Yan Y, Brand RE, Petersen GM, Chari ST, Lai LA, Eng JK, Brentnall TA, Chen R. Systemic Proteome Alterations Linked to Early Stage Pancreatic Cancer in Diabetic Patients. Cancers (Basel). 2020;12(6):1534.","DOI":"10.3390\/cancers12061534"},{"key":"16058_CR9","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jpba.2014.03.047","volume":"101","author":"G la Marca","year":"2014","unstructured":"la Marca G. Mass spectrometry in clinical chemistry: the case of newborn screening. J Pharm Biomed Anal. 2014;101:174\u201382.","journal-title":"J Pharm Biomed Anal"},{"issue":"10","key":"16058_CR10","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1373\/clinchem.2015.253740","volume":"62","author":"JR Mills","year":"2016","unstructured":"Mills JR, Kohlhagen MC, Dasari S, Vanderboom PM, Kyle RA, Katzmann JA, Willrich MA, Barnidge DR, Dispenzieri A, Murray DL. Comprehensive Assessment of M-Proteins Using Nanobody Enrichment Coupled to MALDI-TOF Mass Spectrometry. Clin Chem. 2016;62(10):1334\u201344.","journal-title":"Clin Chem"},{"issue":"6","key":"16058_CR11","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.jpha.2022.08.003","volume":"12","author":"T Mochizuki","year":"2022","unstructured":"Mochizuki T, Shibata K, Naito T, Shimoyama K, Ogawa N, Maekawa M, Kawakami J. LC-MS\/MS method for the quantitation of serum tocilizumab in rheumatoid arthritis patients using rapid tryptic digestion without IgG purification. J Pharm Anal. 2022;12(6):852\u20139.","journal-title":"J Pharm Anal"},{"issue":"1","key":"16058_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14789450.2017.1256777","volume":"14","author":"D Nedelkov","year":"2017","unstructured":"Nedelkov D. Mass spectrometry protein tests: ready for prime time (or not). Expert Rev Proteom. 2017;14(1):1\u20137.","journal-title":"Expert Rev Proteom"},{"issue":"3","key":"16058_CR13","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1093\/clinchem\/hvac204","volume":"69","author":"LR Ruhaak","year":"2023","unstructured":"Ruhaak LR, Romijn F, Begcevic Brkovic I, Kuklenyik Z, Dittrich J, Ceglarek U, Hoofnagle AN, Althaus H, Angles-Cano E, Coassin S, et al. Development of an LC-MRM-MS-Based Candidate Reference Measurement Procedure for Standardization of Serum Apolipoprotein (a) Tests. Clin Chem. 2023;69(3):251\u201361.","journal-title":"Clin Chem"},{"issue":"24","key":"16058_CR14","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1182\/blood-2009-07-230722","volume":"114","author":"JA Vrana","year":"2009","unstructured":"Vrana JA, Gamez JD, Madden BJ, Theis JD, Bergen HR 3rd, Dogan A. Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens. Blood. 2009;114(24):4957\u20139.","journal-title":"Blood"},{"key":"16058_CR15","doi-asserted-by":"crossref","unstructured":"Albrecht V, Muller-Reif J, Nordmann TM, Mund A, Schweizer L, Geyer PE, Niu L, Wang J, Post F, Oeller M et al. Bridging the Gap From Proteomics Technology to Clinical Application: Highlights From the 68th Benzon Foundation Symposium. Mol Cell Proteomics. 2024;23(12):100877.","DOI":"10.1016\/j.mcpro.2024.100877"},{"issue":"3","key":"16058_CR16","first-page":"209","volume":"9","author":"M Cui","year":"2024","unstructured":"Cui M, Deng F, Disis ML, Cheng C, Zhang L. Advances in the Clinical Application of High-throughput Proteomics. Explor Res Hypothesis Med. 2024;9(3):209\u201320.","journal-title":"Explor Res Hypothesis Med"},{"issue":"7","key":"16058_CR17","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1097\/MPA.0b013e3181dac920","volume":"39","author":"R Chen","year":"2010","unstructured":"Chen R, Crispin DA, Pan S, Hawley S, McIntosh MW, May D, Anton-Culver H, Ziogas A, Bronner MP, Brentnall TA. Pilot study of blood biomarker candidates for detection of pancreatic cancer. Pancreas. 2010;39(7):981\u20138.","journal-title":"Pancreas"},{"key":"16058_CR18","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.canlet.2019.11.020","volume":"469","author":"S Pan","year":"2020","unstructured":"Pan S, Brentnall TA, Chen R. Proteome alterations in pancreatic ductal adenocarcinoma. Cancer Lett. 2020;469:429\u201336.","journal-title":"Cancer Lett"},{"issue":"2","key":"16058_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1021\/acs.jproteome.2c00624","volume":"22","author":"EW Deutsch","year":"2023","unstructured":"Deutsch EW, Mendoza L, Shteynberg DD, Hoopmann MR, Sun Z, Eng JK, Moritz RL. Trans-Proteomic Pipeline: Robust Mass Spectrometry-Based Proteomics Data Analysis Suite. J Proteome Res. 2023;22(2):615\u201324.","journal-title":"J Proteome Res"},{"issue":"7","key":"16058_CR20","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1093\/bioinformatics\/btq054","volume":"26","author":"B Maclean","year":"2010","unstructured":"Maclean B, Tomazela DM, Shulman N, Chambers M, Finney GL, Frewen B, Kern R, Tabb DL, Liebler DC, Maccoss MJ. Skyline: an open source document editor for creating and analyzing targeted proteomics experiments. Bioinformatics. 2010;26(7):966\u20138.","journal-title":"Bioinformatics"},{"issue":"8","key":"16058_CR21","doi-asserted-by":"publisher","first-page":"e506","DOI":"10.1002\/ctm2.506","volume":"11","author":"S Pan","year":"2021","unstructured":"Pan S, Brand RE, Lai LA, Dawson DW, Donahue TR, Kim S, Khalaf NI, Othman MO, Fisher WE, Bronner MP, et al. Proteome heterogeneity and malignancy detection in pancreatic cyst fluids. Clin Transl Med. 2021;11(8):e506.","journal-title":"Clin Transl Med"},{"issue":"19","key":"16058_CR22","doi-asserted-by":"publisher","first-page":"5031","DOI":"10.1016\/j.cell.2021.08.023","volume":"184","author":"L Cao","year":"2021","unstructured":"Cao L, Huang C, Cui Zhou D, Hu Y, Lih TM, Savage SR, Krug K, Clark DJ, Schnaubelt M, Chen L, et al. Proteogenomic characterization of pancreatic ductal adenocarcinoma. Cell. 2021;184(19):5031\u2013e50525026.","journal-title":"Cell"},{"issue":"1","key":"16058_CR23","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1038\/s41467-022-30342-3","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Chen F, Chandrashekar DS, Varambally S, Creighton CJ. Proteogenomic characterization of 2002 human cancers reveals pan-cancer molecular subtypes and associated pathways. Nat Commun. 2022;13(1):2669.","journal-title":"Nat Commun"},{"issue":"1","key":"16058_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/imr.13147","volume":"313","author":"A Zarantonello","year":"2023","unstructured":"Zarantonello A, Revel M, Grunenwald A, Roumenina LT. C3-dependent effector functions of complement. Immunol Rev. 2023;313(1):120\u201338.","journal-title":"Immunol Rev"},{"issue":"1","key":"16058_CR25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3892\/ol.2013.1326","volume":"6","author":"J Chen","year":"2013","unstructured":"Chen J, Wu W, Zhen C, Zhou H, Yang R, Chen L, Hu L. Expression and clinical significance of complement C3, complement C4b1 and apolipoprotein E in pancreatic cancer. Oncol Lett. 2013;6(1):43\u20138.","journal-title":"Oncol Lett"},{"key":"16058_CR26","doi-asserted-by":"crossref","unstructured":"Qu J, Ko CW, Tso P, Bhargava A. Apolipoprotein A-IV: A multifunctional protein involved in protection against atherosclerosis and diabetes. Cells. 2019;8(4):319.","DOI":"10.3390\/cells8040319"},{"issue":"1","key":"16058_CR27","doi-asserted-by":"publisher","first-page":"400","DOI":"10.21037\/jgo-21-910","volume":"13","author":"D Cai","year":"2022","unstructured":"Cai D, Chen C, Su Y, Tan Y, Lin X, Xing R. LRG1 in pancreatic cancer cells promotes inflammatory factor synthesis and the angiogenesis of HUVECs by activating VEGFR signaling. J Gastrointest Oncol. 2022;13(1):400\u201312.","journal-title":"J Gastrointest Oncol"},{"key":"16058_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.trsl.2019.06.003","volume":"212","author":"Q Zhou","year":"2019","unstructured":"Zhou Q, Andersson R, Hu D, Bauden M, Sasor A, Bygott T, PawLowski K, Pla I, Marko-Varga G, Ansari D. Alpha-1-acid glycoprotein 1 is upregulated in pancreatic ductal adenocarcinoma and confers a poor prognosis. Transl Res. 2019;212:67\u201379.","journal-title":"Transl Res"},{"issue":"55","key":"16058_CR29","doi-asserted-by":"publisher","first-page":"5703","DOI":"10.18632\/oncotarget.27191","volume":"10","author":"K Osther","year":"2019","unstructured":"Osther K, Fornvik K, Liljedahl E, Salford LG, Redebrandt HN. Upregulation of C1-inhibitor in pancreatic cancer. Oncotarget. 2019;10(55):5703\u201312.","journal-title":"Oncotarget"},{"key":"16058_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1002\/prca.201700064","volume":"11","author":"EN Nigjeh","year":"2017","unstructured":"Nigjeh EN, Chen R, Allen-Tamura Y, Brand RE, Brentnall TA, Pan S. Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer. Proteom Clin Appl. 2017;11:9\u201310.","journal-title":"Proteom Clin Appl"},{"key":"16058_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12014-019-9251-3","volume":"16","author":"H Peng","year":"2019","unstructured":"Peng H, Chen R, Brentnall TA, Eng JK, Picozzi VJ, Pan S. Predictive proteomic signatures for response of pancreatic cancer patients receiving chemotherapy. Clin Proteom. 2019;16:31.","journal-title":"Clin Proteom"},{"key":"16058_CR32","doi-asserted-by":"crossref","unstructured":"Leys CL, Klein C, Bernard O, Licata P. L: Detecting outliers: Do not use standard deviation around the mean, use absolute deviation around the median. J Exp Soc Psychol. 2013;49(4):764\u20136.","DOI":"10.1016\/j.jesp.2013.03.013"},{"issue":"1","key":"16058_CR33","doi-asserted-by":"publisher","first-page":"5","DOI":"10.11613\/BM.2016.001","volume":"26","author":"Y Ozarda","year":"2016","unstructured":"Ozarda Y. Reference intervals: current status, recent developments and future considerations. Biochem Med (Zagreb). 2016;26(1):5\u201316.","journal-title":"Biochem Med (Zagreb)"},{"key":"16058_CR34","doi-asserted-by":"crossref","unstructured":"Henny J. The IFCC recommendations for determining reference intervals: strengths and limitations. J Lab Med. 2009;33(2):45\u201351.","DOI":"10.1515\/JLM.2009.016"},{"issue":"3","key":"16058_CR35","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1515\/cclm-2016-0793_C","volume":"55","author":"J Henny","year":"2017","unstructured":"Henny J, Vassault A, Boursier G, Vukasovic I, Brguljan PM, Lohmander M, Ghita I, Andreu FA, Kroupis C, Sprongl L, et al. Corrigendum to: Recommendation for the review of biological reference intervals in medical laboratories. Clin Chem Lab Med. 2017;55(3):470.","journal-title":"Clin Chem Lab Med"},{"issue":"8","key":"16058_CR36","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1074\/mcp.M700072-MCP200","volume":"6","author":"R Chen","year":"2007","unstructured":"Chen R, Brentnall TA, Pan S, Cooke K, Moyes KW, Lane Z, Crispin DA, Goodlett DR, Aebersold R, Bronner MP. Quantitative proteomics analysis reveals that proteins differentially expressed in chronic pancreatitis are also frequently involved in pancreatic cancer. Mol Cell Proteom. 2007;6(8):1331\u201342.","journal-title":"Mol Cell Proteom"},{"issue":"1","key":"16058_CR37","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/01.mpa.0000240615.20474.fd","volume":"34","author":"R Chen","year":"2007","unstructured":"Chen R, Pan S, Cooke K, Moyes KW, Bronner MP, Goodlett DR, Aebersold R, Brentnall TA. Comparison of pancreas juice proteins from cancer versus pancreatitis using quantitative proteomic analysis. Pancreas. 2007;34(1):70\u20139.","journal-title":"Pancreas"},{"issue":"11","key":"16058_CR38","doi-asserted-by":"publisher","first-page":"e27574","DOI":"10.1371\/journal.pone.0027574","volume":"6","author":"S Pan","year":"2011","unstructured":"Pan S, Chen R, Stevens T, Bronner MP, May D, Tamura Y, McIntosh MW, Brentnall TA. Proteomics portrait of archival lesions of chronic pancreatitis. PLoS ONE. 2011;6(11):e27574.","journal-title":"PLoS ONE"},{"issue":"1","key":"16058_CR39","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/S1470-2045(08)70337-1","volume":"10","author":"R Pannala","year":"2009","unstructured":"Pannala R, Basu A, Petersen GM, Chari ST. New-onset diabetes: a potential clue to the early diagnosis of pancreatic cancer. Lancet Oncol. 2009;10(1):88\u201395.","journal-title":"Lancet Oncol"},{"issue":"5","key":"16058_CR40","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1001\/jama.2019.6190","volume":"322","author":"NB Henrikson","year":"2019","unstructured":"Henrikson NB, Aiello Bowles EJ, Blasi PR, Morrison CC, Nguyen M, Pillarisetty VG, Lin JS. Screening for Pancreatic Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2019;322(5):445\u201354.","journal-title":"JAMA"},{"issue":"11","key":"16058_CR41","doi-asserted-by":"publisher","first-page":"907","DOI":"10.5306\/wjco.v13.i11.907","volume":"13","author":"D Lew","year":"2022","unstructured":"Lew D, Kamal F, Phan K, Randhawa K, Cornwell S, Bangolo AI, Weissman S, Pandol SJ. Epidemiologic risk factors for patients admitted with chronic pancreatitis and pancreatic ductal adenocarcinoma in the United States. World J Clin Oncol. 2022;13(11):907\u201317.","journal-title":"World J Clin Oncol"},{"issue":"2","key":"16058_CR42","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.gastro.2005.05.007","volume":"129","author":"ST Chari","year":"2005","unstructured":"Chari ST, Leibson CL, Rabe KG, Ransom J, de Petersen AM. Probability of pancreatic cancer following diabetes: a population-based study. Gastroenterology. 2005;129(2):504\u201311.","journal-title":"Gastroenterology"},{"issue":"9","key":"16058_CR43","doi-asserted-by":"publisher","first-page":"2358","DOI":"10.3748\/wjg.v20.i9.2358","volume":"20","author":"MC Chang","year":"2014","unstructured":"Chang MC, Wong JM, Chang YT. Screening and early detection of pancreatic cancer in high risk population. World J Gastroenterol. 2014;20(9):2358\u201364.","journal-title":"World J Gastroenterol"},{"issue":"10","key":"16058_CR44","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1158\/2767-9764.CRC-22-0190","volume":"2","author":"LE Kane","year":"2022","unstructured":"Kane LE, Mellotte GS, Mylod E, O\u2019Brien RM, O\u2019Connell F, Buckley CE, Arlow J, Nguyen K, Mockler D, Meade AD, et al. Diagnostic Accuracy of Blood-based Biomarkers for Pancreatic Cancer: A Systematic Review and Meta-analysis. Cancer Res Commun. 2022;2(10):1229\u201343.","journal-title":"Cancer Res Commun"},{"issue":"4","key":"16058_CR45","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1053\/j.gastro.2005.08.001","volume":"129","author":"R Chen","year":"2005","unstructured":"Chen R, Yi EC, Donohoe D, Pan S, Eng J, Crispin DA, Lane Z, Goodlett DA, Bronner MP, Aebersold R, et al. Pancreatic Cancer Proteome: the Proteins that Underlie Invasion, Metastasis, and Immunologic Escape. Gastroenterology. 2005;129(4):1187\u201397.","journal-title":"Gastroenterology"},{"issue":"7","key":"16058_CR46","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1002\/elps.200800752","volume":"30","author":"S Pan","year":"2009","unstructured":"Pan S, Chen R, Reimel BA, Crispin DA, Mirzaei H, Cooke K, Coleman JF, Lane Z, Bronner MP, Goodlett DR, et al. Quantitative proteomics investigation of pancreatic intraepithelial neoplasia. Electrophoresis. 2009;30(7):1132\u201344.","journal-title":"Electrophoresis"},{"issue":"1","key":"16058_CR47","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s13046-019-1088-0","volume":"38","author":"ZB Xie","year":"2019","unstructured":"Xie ZB, Zhang YF, Jin C, Mao YS, Fu DL. LRG-1 promotes pancreatic cancer growth and metastasis via modulation of the EGFR\/p38 signaling. J Exp Clin Cancer Res. 2019;38(1):75.","journal-title":"J Exp Clin Cancer Res"},{"issue":"5","key":"16058_CR48","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1053\/j.gastro.2019.12.009","volume":"158","author":"C Frere","year":"2020","unstructured":"Frere C, Bournet B, Gourgou S, Fraisse J, Canivet C, Connors JM, Buscail L, Farge D, Consortium B. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes. Gastroenterology. 2020;158(5):1346\u2013e13581344.","journal-title":"Gastroenterology"},{"key":"16058_CR49","doi-asserted-by":"crossref","unstructured":"Capello M, Bantis LE, Scelo G, Zhao Y, Li P, Dhillon DS, Patel NJ, Kundnani DL, Wang H, Abbruzzese JL, et al. Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer. J Natl Cancer Inst. 2017;109(4):djw266.","DOI":"10.1093\/jnci\/djw266"},{"key":"16058_CR50","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.jprot.2014.10.001","volume":"113","author":"C Jenkinson","year":"2015","unstructured":"Jenkinson C, Elliott V, Menon U, Apostolidou S, Fourkala OE, Gentry-Maharaj A, Pereira SP, Jacobs I, Cox TF, Greenhalf W, et al. Evaluation in pre-diagnosis samples discounts ICAM-1 and TIMP-1 as biomarkers for earlier diagnosis of pancreatic cancer. J Proteom. 2015;113:400\u20132.","journal-title":"J Proteom"},{"issue":"1","key":"16058_CR51","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12885-018-4055-9","volume":"18","author":"O Prokopchuk","year":"2018","unstructured":"Prokopchuk O, Grunwald B, Nitsche U, Jager C, Prokopchuk OL, Schubert EC, Friess H, Martignoni ME, Kruger A. Elevated systemic levels of the matrix metalloproteinase inhibitor TIMP-1 correlate with clinical markers of cachexia in patients with chronic pancreatitis and pancreatic cancer. BMC Cancer. 2018;18(1):128.","journal-title":"BMC Cancer"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16058-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16058-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16058-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T03:52:55Z","timestamp":1780631575000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16058-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16058"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16058-3","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"1 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Research involving human material and data has been performed in accordance with the Declaration of Helsinki. The study was approved by the Institutional Review Boards at the University of Pittsburgh, University of Washington, Baylor College of Medicine, and University of Texas Health Science Center at Houston. All samples used in this study were exclusively anonymized samples. These samples were collected from previous clinical studies with informed consent obtained from all subjects before participation.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The University of Texas Health Science Center at Houston has submitted a patent application, in which some authors are listed as inventors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"717"}}